• Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
Economy

Senate confirms Dr Marty Makary as Trump’s FDA chief

by March 26, 2025
by March 26, 2025

President Donald Trump’s choice to lead the Food and Drug Administration (FDA), Johns Hopkins School of Medicine professor Dr. Marty Makary, was confirmed in the Senate on Tuesday.

His confirmation was cemented just hours after he cleared one last procedural test vote earlier in the evening. 

The Senate voted 56-44 to invoke cloture on the nomination prior to his final confirmation.

Makary, a former Fox News medical contributor, went before the Senate Committee on Health, Education, Labor and Pensions (HELP) earlier this month and answered various questions on vaccines, chronic illness, food safety and abortion. 

During his hearing, the nominee faced scrutiny over an FDA vaccine meeting that was reportedly postponed at the last minute. 

‘So if you are confirmed, will you commit to immediately reschedule that FDA Vaccine Advisory Committee meeting to get the expert views?’ Sen. Patty Murray, D-Wash., asked Makary at the time. 

He responded that he ‘would reevaluate which topics deserve a convening of the advisory committee members on [Vaccines and Related Biological Products Advisory Committee] and which may not require a convening.’ 

When this response wasn’t good enough for Murray, Makary flipped the question, telling her to confront the Biden administration. ‘Well, you can ask the Biden administration that chose not to convene the committee meeting for the COVID vaccine booster,’ he said. 

He was referring to the Biden administration in 2021 pushing through FDA approval for a COVID-19 booster for everyone over the age of 18. 

‘The FDA did not hold a meeting of the Vaccines and Related Biological Products Advisory Committee on these actions,’ read a press release at the time, ‘as the agency previously convened the committee for extensive discussions regarding the use of booster doses of COVID-19 vaccines and, after review of both Pfizer’s and Moderna’s EUA requests, the FDA concluded that the requests do not raise questions that would benefit from additional discussion by committee members.’

Committee member Dr. Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia, criticized the administration’s move, saying, ‘We’re being asked to approve this as a three-dose vaccine for people 16 years of age and older, without any clear evidence if the third dose for a younger person when compared to an elderly person is of value.’

Makary has long been a critic of the administration he will now lead. He wrote an opinion piece in 2021, calling for ‘fresh leadership at the FDA to change the culture at the agency and promote scientific advancement, not hinder it.’

‘We now have a generational opportunity in American healthcare,’ he said at his hearing. ‘President Trump and Secretary Kennedy’s focus on healthy foods has galvanized a grassroots movement in America. Childhood obesity is not a willpower problem, and the rise of early-onset Alzheimer’s is not a genetic cause. We should be, and we will, be addressing food as it impacts our health.’

This post appeared first on FOX NEWS

0 comment
0
FacebookTwitterPinterestEmail

previous post
GOP senator says Dr Oz ignored his questions on transgender issues, abortion
next post
Trump FDA pick clears last hurdle after flipping vaccine question on Dem in confirmation hearing

Related Posts

Are We Doomed to Repeat Economic History, Even...

August 29, 2025

Is Trump considering bold Africa play to push...

August 29, 2025

What did Obama know about the Trump–Russia probe?...

August 29, 2025

UK, France, Germany trigger UN sanctions on Iran...

August 29, 2025

Trump pick for UN aviation office has long...

August 29, 2025

US agencies distance themselves from Chinese-founded PDF software

August 29, 2025

Bipartisan fury at CDC: Senators demand probe, reject...

August 29, 2025

CDC official includes ‘pregnant people’ terminology and pronouns...

August 29, 2025

Bolivia’s Defeat of Socialism Signals a Continental Realignment

August 28, 2025

Economic Measurement and the Mirage of Exactness

August 28, 2025

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Recent Posts

  • Are We Doomed to Repeat Economic History, Even When We Know It?

    August 29, 2025
  • US tariff: Why your online orders from overseas might cost more now

    August 29, 2025
  • China’s offshore wind power surges ahead with cost edge over Europe and US

    August 29, 2025
  • Forever 21 plans China comeback with Chengdi, eyes North America relaunch

    August 29, 2025
  • Europe markets open: FTSE futures point up, DAX slips as a deluge of inflation data awaits

    August 29, 2025
  • China ups soybean imports from Argentina, Uruguay as US trade war deepens

    August 29, 2025

Editors’ Picks

  • 1

    Meta executives eligible for 200% salary bonus under new pay structure

    February 21, 2025
  • 2

    Walmart earnings preview: What to expect before Thursday’s opening bell

    February 20, 2025
  • 3

    New FBI leader Kash Patel tapped to run ATF as acting director

    February 23, 2025
  • 4

    Anthropic’s newly released Claude 3.7 Sonnet can ‘think’ as long as the user wants before giving an answer

    February 25, 2025
  • 5

    Cramer reveals a sub-sector of technology that can withstand Trump tariffs

    March 1, 2025
  • 6

    Nvidia’s investment in SoundHound wasn’t all that significant after all

    March 1, 2025
  • 7

    Elon Musk says federal employees must fill out productivity reports or resign

    February 23, 2025

Categories

  • Economy (2,364)
  • Editor's Pick (228)
  • Investing (185)
  • Stock (1,603)
  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 Portfolioperformancetoday.com All Rights Reserved.

Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Copyright © 2025 Portfolioperformancetoday.com All Rights Reserved.

Read alsox

The Fed’s Triple Mandate Problem: It’s Time...

March 5, 2025

Judge who blocked key Trump executive order...

March 20, 2025

The Resurgence of Do It Yourself Economics 

June 12, 2025